The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Losartan Potassium Tablets Market Research Report 2024

Global Losartan Potassium Tablets Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1764498

No of Pages : 99

Synopsis
Global Losartan Potassium Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Losartan Potassium Tablets market research.

Key manufacturers engaged in the Losartan Potassium Tablets industry include Zhejiang NuoDe Pharmaceutical Co., Ltd., Organon & Co., Sandoz, Meiji Seika Pharma Co.Ltd., Zhejiang Huahai Pharmaceutical Co.,Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., Chongqing Kerui Pharmaceutical (Group) Co., Ltd., Reddy's Laboratories and Torrent Pharmaceuticals Limited, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Losartan Potassium Tablets were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Losartan Potassium Tablets market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Losartan Potassium Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Zhejiang NuoDe Pharmaceutical Co., Ltd.
  • Organon & Co.
  • Sandoz
  • Meiji Seika Pharma Co.Ltd.
  • Zhejiang Huahai Pharmaceutical Co.,Ltd.
  • Yangtze River Pharmaceutical (Group) Co., Ltd.
  • Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
  • Reddy's Laboratories
  • Torrent Pharmaceuticals Limited
  • Camber Pharmaceuticals, Inc
  • Teva Pharmaceuticals

Segment by Type

  • 25mg
  • 50mg
  • 100mg

Segment by Application

  • Hospital
  • Clinic
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil,Turkey, GCC Countries)

The Losartan Potassium Tablets report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Losartan Potassium Tablets Market Overview
1.1 Product Overview and Scope of Losartan Potassium Tablets
1.2 Losartan Potassium Tablets Segment by Type
1.2.1 Global Losartan Potassium Tablets Market Value Comparison by Type (2023-2029)
1.2.2 25mg
1.2.3 50mg
1.2.4 100mg
1.3 Losartan Potassium Tablets Segment by Application
1.3.1 Global Losartan Potassium Tablets Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Losartan Potassium Tablets Market Size Estimates and Forecasts
1.4.1 Global Losartan Potassium Tablets Revenue 2018-2029
1.4.2 Global Losartan Potassium Tablets Sales 2018-2029
1.4.3 Global Losartan Potassium Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Losartan Potassium Tablets Market Competition by Manufacturers
2.1 Global Losartan Potassium Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Losartan Potassium Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Losartan Potassium Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Losartan Potassium Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Losartan Potassium Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Losartan Potassium Tablets, Product Type & Application
2.7 Losartan Potassium Tablets Market Competitive Situation and Trends
2.7.1 Losartan Potassium Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Losartan Potassium Tablets Players Market Share by Revenue
2.7.3 Global Losartan Potassium Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Losartan Potassium Tablets Retrospective Market Scenario by Region
3.1 Global Losartan Potassium Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Losartan Potassium Tablets Global Losartan Potassium Tablets Sales by Region: 2018-2029
3.2.1 Global Losartan Potassium Tablets Sales by Region: 2018-2023
3.2.2 Global Losartan Potassium Tablets Sales by Region: 2024-2029
3.3 Global Losartan Potassium Tablets Global Losartan Potassium Tablets Revenue by Region: 2018-2029
3.3.1 Global Losartan Potassium Tablets Revenue by Region: 2018-2023
3.3.2 Global Losartan Potassium Tablets Revenue by Region: 2024-2029
3.4 North America Losartan Potassium Tablets Market Facts & Figures by Country
3.4.1 North America Losartan Potassium Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Losartan Potassium Tablets Sales by Country (2018-2029)
3.4.3 North America Losartan Potassium Tablets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Losartan Potassium Tablets Market Facts & Figures by Country
3.5.1 Europe Losartan Potassium Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Losartan Potassium Tablets Sales by Country (2018-2029)
3.5.3 Europe Losartan Potassium Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Losartan Potassium Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Losartan Potassium Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Losartan Potassium Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Losartan Potassium Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Losartan Potassium Tablets Market Facts & Figures by Country
3.7.1 Latin America Losartan Potassium Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Losartan Potassium Tablets Sales by Country (2018-2029)
3.7.3 Latin America Losartan Potassium Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Losartan Potassium Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Losartan Potassium Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Losartan Potassium Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Losartan Potassium Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Losartan Potassium Tablets Sales by Type (2018-2029)
4.1.1 Global Losartan Potassium Tablets Sales by Type (2018-2023)
4.1.2 Global Losartan Potassium Tablets Sales by Type (2024-2029)
4.1.3 Global Losartan Potassium Tablets Sales Market Share by Type (2018-2029)
4.2 Global Losartan Potassium Tablets Revenue by Type (2018-2029)
4.2.1 Global Losartan Potassium Tablets Revenue by Type (2018-2023)
4.2.2 Global Losartan Potassium Tablets Revenue by Type (2024-2029)
4.2.3 Global Losartan Potassium Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Losartan Potassium Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Losartan Potassium Tablets Sales by Application (2018-2029)
5.1.1 Global Losartan Potassium Tablets Sales by Application (2018-2023)
5.1.2 Global Losartan Potassium Tablets Sales by Application (2024-2029)
5.1.3 Global Losartan Potassium Tablets Sales Market Share by Application (2018-2029)
5.2 Global Losartan Potassium Tablets Revenue by Application (2018-2029)
5.2.1 Global Losartan Potassium Tablets Revenue by Application (2018-2023)
5.2.2 Global Losartan Potassium Tablets Revenue by Application (2024-2029)
5.2.3 Global Losartan Potassium Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Losartan Potassium Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Zhejiang NuoDe Pharmaceutical Co., Ltd.
6.1.1 Zhejiang NuoDe Pharmaceutical Co., Ltd. Corporation Information
6.1.2 Zhejiang NuoDe Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Zhejiang NuoDe Pharmaceutical Co., Ltd. Losartan Potassium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Zhejiang NuoDe Pharmaceutical Co., Ltd. Losartan Potassium Tablets Product Portfolio
6.1.5 Zhejiang NuoDe Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Organon & Co.
6.2.1 Organon & Co. Corporation Information
6.2.2 Organon & Co. Description and Business Overview
6.2.3 Organon & Co. Losartan Potassium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Organon & Co. Losartan Potassium Tablets Product Portfolio
6.2.5 Organon & Co. Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Corporation Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Losartan Potassium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sandoz Losartan Potassium Tablets Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Meiji Seika Pharma Co.Ltd.
6.4.1 Meiji Seika Pharma Co.Ltd. Corporation Information
6.4.2 Meiji Seika Pharma Co.Ltd. Description and Business Overview
6.4.3 Meiji Seika Pharma Co.Ltd. Losartan Potassium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Meiji Seika Pharma Co.Ltd. Losartan Potassium Tablets Product Portfolio
6.4.5 Meiji Seika Pharma Co.Ltd. Recent Developments/Updates
6.5 Zhejiang Huahai Pharmaceutical Co.,Ltd.
6.5.1 Zhejiang Huahai Pharmaceutical Co.,Ltd. Corporation Information
6.5.2 Zhejiang Huahai Pharmaceutical Co.,Ltd. Description and Business Overview
6.5.3 Zhejiang Huahai Pharmaceutical Co.,Ltd. Losartan Potassium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Zhejiang Huahai Pharmaceutical Co.,Ltd. Losartan Potassium Tablets Product Portfolio
6.5.5 Zhejiang Huahai Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.6 Yangtze River Pharmaceutical (Group) Co., Ltd.
6.6.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Corporation Information
6.6.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.6.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Losartan Potassium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Losartan Potassium Tablets Product Portfolio
6.6.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.7 Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
6.6.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Corporation Information
6.6.2 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.6.3 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Losartan Potassium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Losartan Potassium Tablets Product Portfolio
6.7.5 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.8 Reddy's Laboratories
6.8.1 Reddy's Laboratories Corporation Information
6.8.2 Reddy's Laboratories Description and Business Overview
6.8.3 Reddy's Laboratories Losartan Potassium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Reddy's Laboratories Losartan Potassium Tablets Product Portfolio
6.8.5 Reddy's Laboratories Recent Developments/Updates
6.9 Torrent Pharmaceuticals Limited
6.9.1 Torrent Pharmaceuticals Limited Corporation Information
6.9.2 Torrent Pharmaceuticals Limited Description and Business Overview
6.9.3 Torrent Pharmaceuticals Limited Losartan Potassium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Torrent Pharmaceuticals Limited Losartan Potassium Tablets Product Portfolio
6.9.5 Torrent Pharmaceuticals Limited Recent Developments/Updates
6.10 Camber Pharmaceuticals, Inc
6.10.1 Camber Pharmaceuticals, Inc Corporation Information
6.10.2 Camber Pharmaceuticals, Inc Description and Business Overview
6.10.3 Camber Pharmaceuticals, Inc Losartan Potassium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Camber Pharmaceuticals, Inc Losartan Potassium Tablets Product Portfolio
6.10.5 Camber Pharmaceuticals, Inc Recent Developments/Updates
6.11 Teva Pharmaceuticals
6.11.1 Teva Pharmaceuticals Corporation Information
6.11.2 Teva Pharmaceuticals Losartan Potassium Tablets Description and Business Overview
6.11.3 Teva Pharmaceuticals Losartan Potassium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Teva Pharmaceuticals Losartan Potassium Tablets Product Portfolio
6.11.5 Teva Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Losartan Potassium Tablets Industry Chain Analysis
7.2 Losartan Potassium Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Losartan Potassium Tablets Production Mode & Process
7.4 Losartan Potassium Tablets Sales and Marketing
7.4.1 Losartan Potassium Tablets Sales Channels
7.4.2 Losartan Potassium Tablets Distributors
7.5 Losartan Potassium Tablets Customers
8 Losartan Potassium Tablets Market Dynamics
8.1 Losartan Potassium Tablets Industry Trends
8.2 Losartan Potassium Tablets Market Drivers
8.3 Losartan Potassium Tablets Market Challenges
8.4 Losartan Potassium Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’